<?xml version="1.0" encoding="UTF-8"?>
<ref id="B14-nanomaterials-10-01072">
 <label>14.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Mazur</surname>
    <given-names>N.I.</given-names>
   </name>
   <name>
    <surname>Higgins</surname>
    <given-names>D.</given-names>
   </name>
   <name>
    <surname>Nunes</surname>
    <given-names>M.C.</given-names>
   </name>
   <name>
    <surname>Melero</surname>
    <given-names>J.A.</given-names>
   </name>
   <name>
    <surname>Langedijk</surname>
    <given-names>A.C.</given-names>
   </name>
   <name>
    <surname>Horsley</surname>
    <given-names>N.</given-names>
   </name>
   <name>
    <surname>Buchholz</surname>
    <given-names>U.J.</given-names>
   </name>
   <name>
    <surname>Openshaw</surname>
    <given-names>P.J.</given-names>
   </name>
   <name>
    <surname>McLellan</surname>
    <given-names>J.S.</given-names>
   </name>
   <name>
    <surname>Englund</surname>
    <given-names>J.A.</given-names>
   </name>
  </person-group>
  <article-title>The respiratory syncytial virus vaccine landscape: Lessons from the graveyard and promising candidates</article-title>
  <source>Lancet Infect. Dis.</source>
  <year>2018</year>
  <volume>18</volume>
  <fpage>e295</fpage>
  <lpage>e311</lpage>
  <pub-id pub-id-type="doi">10.1016/S1473-3099(18)30292-5</pub-id>
  <pub-id pub-id-type="pmid">29914800</pub-id>
 </element-citation>
</ref>
